WallStSmart

Barrick Mining Corporation (B)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Barrick Mining Corporation generates 452% more annual revenue ($16.96B vs $3.07B). B leads profitability with a 29.4% profit margin vs 16.1%. B appears more attractively valued with a PEG of 2.04. B earns a higher WallStSmart Score of 81/100 (A-).

B

Exceptional Buy

81

out of 100

Grade: A-

Growth: 9.3Profit: 9.0Value: 10.0Quality: 8.5
Piotroski: 7/9Altman Z: 2.38

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BUndervalued (+65.3%)

Margin of Safety

+65.3%

Fair Value

$137.12

Current Price

$37.69

$99.43 discount

UndervaluedFair: $137.12Overvalued
WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$247.02

$178.03 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

B6 strengths · Avg: 9.5/10
Operating MarginProfitability
52.6%10/10

Strong operational efficiency at 52.6%

Revenue GrowthGrowth
64.5%10/10

Revenue surging 64.5% year-over-year

EPS GrowthGrowth
150.0%10/10

Earnings expanding 150.0% YoY

Market CapQuality
$62.59B9/10

Large-cap with strong market position

Return on EquityProfitability
20.7%9/10

Every $100 of equity generates 21 in profit

Profit MarginProfitability
29.4%9/10

Keeps 29 of every $100 in revenue as profit

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

B1 concerns · Avg: 4.0/10
PEG RatioValuation
2.044/10

Expensive relative to growth rate

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : B

The strongest argument for B centers on Operating Margin, Revenue Growth, EPS Growth. Profitability is solid with margins at 29.4% and operating margin at 52.6%. Revenue growth of 64.5% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : B

The primary concerns for B are PEG Ratio.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

B profiles as a growth stock while WST is a mature play — different risk/reward profiles.

WST carries more volatility with a beta of 1.18 — expect wider price swings.

B is growing revenue faster at 64.5% — sustainability is the question.

B generates stronger free cash flow (1.4B), providing more financial flexibility.

Bottom Line

B scores higher overall (81/100 vs 55/100), backed by strong 29.4% margins and 64.5% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Barrick Mining Corporation

BASIC MATERIALS · GOLD · USA

Barnes Group Inc. provides engineering products, industrial technologies, and solutions in the United States and internationally. The company is headquartered in Bristol, Connecticut.

Visit Website →

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?